A61P 25/12
For grand-mal
Official title: for grand-mal
A61P25/12 (For grand-mal) appears on 168 US grants and 268 published applications in this corpus.
Search patents in A61P- Granted patents
- 168
- Published applications
- 268
- Assignees
- 124
- Inventors
- 572
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 2 |
| 2002 | 0 | 4 |
| 2003 | 6 | 7 |
| 2004 | 0 | 16 |
| 2005 | 4 | 13 |
| 2006 | 6 | 26 |
| 2007 | 12 | 23 |
| 2008 | 8 | 17 |
| 2009 | 10 | 26 |
| 2010 | 12 | 19 |
| 2011 | 15 | 14 |
| 2012 | 11 | 13 |
| 2013 | 10 | 13 |
| 2014 | 17 | 12 |
| 2015 | 10 | 11 |
| 2016 | 8 | 5 |
| 2017 | 4 | 6 |
| 2018 | 5 | 1 |
| 2019 | 2 | 5 |
| 2020 | 7 | 9 |
| 2021 | 3 | 3 |
| 2022 | 2 | 6 |
| 2023 | 2 | 4 |
| 2024 | 4 | 5 |
| 2025 | 1 | 4 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities22 Sep 2026US 12,740,992 B2Jazz Pharmaceuticals Research UK Limited
- Oxadiazole derivative12 May 2026US 12,624,011 B2Sumitomo Pharma Co., Ltd.
- Use of cannabinoids in the treatment of epilepsy12 Aug 2025US 12,383,567 B2Jazz Pharmaceuticals Research UK Limited
- Water-based cannabinoid and opioid compositions10 Dec 2024US 12,161,723 B2Day Three Labs Manufacturing Inc.
- Use of cannabinoids in the treatment of epilepsy20 Aug 2024US 12,064,399 B2Jazz Pharmaceuticals Research UK Limited
- Oxadiazole derivative20 Aug 2026US 2026/0242345 A1Sumitomo Pharma Co., Ltd.
- Antisense oligomers for treatment of conditions and diseases6 Aug 2026US 2026/0226467 A1Stoke Therapeutics, Inc.
- Cannabidiol for the treatment of refractory seizures23 Jul 2026US 2026/0207635 A1Harmony Biosciences Management, Inc.
- Methods of treatment19 Feb 2026US 2026/0048069 A1Arena Pharmaceuticals, Inc.
- Pharmaceutical combination for preventing or treating epileptic seizure and the use thereof10 Jul 2025US 2025/0222057 A1Fu Jen Catholic University
Most cited
By later US patents
- Method for classifying and treating physiologic brain imbalances using quantitative EEG182US 6,622,036 B1CNS Response, Inc. · 2003
- Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy74US 9,066,920 B2GW Pharma Limited · 2015
- Drug delivery system for administering an adjustable preset dose62US 7,329,241 B2Valeant Pharmaceuticals North America · 2008
- Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy62US 9,522,123 B2GW Pharma Limited · 2016
- Use of cannabinoids in the treatment of epilepsy56US 10,709,671 B2GW Research Limited · 2020